Fuchun Si

No. 156 Jinshui East Road
Zhengzhou, 450046, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

23-hydroxybetulinic acid induces cell cycle arrest in esophageal cancer cells via the BUB1/STAT3 signaling pathway.

23-hydroxybetulinic acid induces cell cycle arrest in esophageal cancer cells via the BUB1/STAT3 signaling pathway.

Journal: Frontiers in oncology
Published: February 05, 2026

A migration/invasion-related prognostic signature identifies and functionally validates SLC25A5 as a hub associated with spliceosome programs and invasive phenotypes in esophageal squamous cell carcinoma.

A migration/invasion-related prognostic signature identifies and functionally validates SLC25A5 as a hub associated with spliceosome programs and invasive phenotypes in esophageal squamous cell carcinoma.

Journal: Functional & integrative genomics
Published: January 05, 2026

Single-cell RNA-seq reveals breast cancer heterogeneity and identifies TCP1 as a therapeutic target in breast cancer.

Single-cell RNA-seq reveals breast cancer heterogeneity and identifies TCP1 as a therapeutic target in breast cancer.

Journal: PeerJ
Published: June 30, 2025

Integration of single-cell RNA and bulk RNA sequencing revealed malignant ductal cell heterogeneity and prognosis signatures in pancreatic cancer.

Integration of single-cell RNA and bulk RNA sequencing revealed malignant ductal cell heterogeneity and prognosis signatures in pancreatic cancer.

Journal: Frontiers in immunology
Published: February 18, 2025

Single-cell RNA sequencing reveals the role of GTF2F2 in ovarian cancer oncogenesis and progression.

Single-cell RNA sequencing reveals the role of GTF2F2 in ovarian cancer oncogenesis and progression.

Journal: Journal of ovarian research
Published: February 18, 2025

Mediating role of circulating inflammatory proteins in the effect of immune cells on esophageal cancer risk: A Mendelian randomization study.

Mediating role of circulating inflammatory proteins in the effect of immune cells on esophageal cancer risk: A Mendelian randomization study.

Journal: Medicine
Published: November 04, 2024

Association of immune cells and the risk of esophageal cancer: A Mendelian randomization study in a East Asian population.

Association of immune cells and the risk of esophageal cancer: A Mendelian randomization study in a East Asian population.

Journal: Medicine
Published: May 03, 2024

Association of B cells and the risk of Esophageal cancer: a bidirectional two-sample mendelian randomization study.

Association of B cells and the risk of Esophageal cancer: a bidirectional two-sample mendelian randomization study.

Journal: BMC cancer
Published: April 17, 2024

Combining WO3@AuNPs with Poly(amidoamine) Allows Sensitive Electrochemical Detection of DR1 Based on Dual Signal Amplification.

Combining WO3@AuNPs with Poly(amidoamine) Allows Sensitive Electrochemical Detection of DR1 Based on Dual Signal Amplification.

Journal: ChemPlusChem
Published: February 10, 2024

Baitouweng decoction suppresses growth of esophageal carcinoma cells through miR-495-3p/BUB1/STAT3 axis.

Baitouweng decoction suppresses growth of esophageal carcinoma cells through miR-495-3p/BUB1/STAT3 axis.

Journal: World journal of gastrointestinal oncology
Published: January 20, 2024

Treg cells as a protective factor for Hashimoto`s thyroiditis: a Mendelian randomization study.

Treg cells as a protective factor for Hashimoto`s thyroiditis: a Mendelian randomization study.

Journal: Frontiers in endocrinology
Published: December 01, 2023

Mendelian Randomization Validates the Immune Landscape Mediated by Aggrephagy in Esophageal Squamous Cell Carcinoma Patients from the Perspectives of Multi-omics.

Mendelian Randomization Validates the Immune Landscape Mediated by Aggrephagy in Esophageal Squamous Cell Carcinoma Patients from the Perspectives of Multi-omics.

Journal: Journal of Cancer
Published: December 01, 2023
Showing 1-12 of 23

Last Updated: 09/26/2026